Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: An involvement of opioid receptors in the effect

Brain Research

Volumn 940, Issue 1-2, 2002, Pages 69-78

  Li, Ying ^a   Li, Jin Ju ^a   Yu, Long Chuan ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Opioid receptor; Opioid receptor; Anti nociception; Neuropeptide Y (NPY); Nucleus accumbens; Y1 receptor

Indexed keywords

BETA FUNALTREXAMINE; BINALTORPHIMINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [28-36]; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; OPIATE ANTAGONIST; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; LATENT PERIOD; MALE; MECHANICAL STIMULATION; NERVE STIMULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; THERMAL STIMULATION;

ANIMALS; CATHETERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAT; MALE; MICROINJECTIONS; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NEUROPEPTIDE Y; NUCLEUS ACCUMBENS; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; PHYSICAL STIMULATION; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, OPIOID;

EID: 0037076829     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02594-5     Document Type: Article

References (42)

1. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions
2. The role of dopamine in the nucleus accumbens in analgesia
3. Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via sigma receptors
4. Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation
5. Naloxone blocks `anxiolytic' effects of neuropeptide Y
6. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: Comparison with clocinnamox, β-funaltrexamine, and β-chlornaltrexamine
7. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system - II. Immunohistochemical analysis
8. A receptor subtype involved in neuropeptide-Y-induced food intake
9. Neuropeptide Y: Anatomical distribution and possible function in mammalian nervous system
10. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior
11. The antinociceptive effects of spinally administered neuropeptide Y in the rat: Systematic studies on structure-activity relationship
12. Molecular characterization of the ligand-receptor interaction of neuropeptide Y
13. 3H]β-funaltrexamine
14. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study
15. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain
16. Alkylation of mu opioid effects by β-funaltrexamine in vivo: Comparison of the effects on in situ binding and heroin self-administration in rats
17. Neuropeptide Y in the rat nucleus accumbens: Ultrastructural localization in aspiny neurons receiving synaptic input from GABAergic terminals
18. Effect on nociception of intracerebroventricular administration of low doses of neuropeptide Y in mice
19. Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system
20. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats
21. Characteristics of dose-dependent antagonism by β-funaltrexamine of the antinociceptive effects of intrathecal mu agonists
22. Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor
23. Regional distribution of Y-receptor subtype mRNA in rat brain
24. GABAergic neurons that contain neuropeptide Y selectively target cells with the neurokinin 1 receptor in laminae III and IV of the rat spinal cord
25. Gamma-aminobutyric acid levels in the intercellular space in the nucleus accumbens of the rat brain during a nociceptive conditioned response
26. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor
27. The irreversible antagonistic properties of the fumaramate methyl ester derivative of naltrexone
28. Affinity labels for opioid receptors
29. Antinociceptive effects induced by intra-periaqueductal grey administration of neuropeptide Y in rats
30. Anti-nociceptive effect of neuropeptide Y in periaqueductal grey in rats with inflammation
31. Pharmacological characterization in vivo of the novel opiate, b-funaltrexamine
32. Central nervous system pharmacology of neuropeptide Y
33. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain
34. The effect of intrathecal selective agonists of Y1 and Y2 neuropeptide Y receptors on the flexor reflex in normal and axotomized rats
35. Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors
36. The neural pathway from nucleus accumbens to amygdala in morphine analgesia of the rabbit
37. Involvement of arcuate nucleus of hypothalamus in the descending pathway from nucleus accumbens to periaqueductal grey subserving an antinociceptive effect
38. Opioid antagonists naloxone, β-funaltrexamine and naltrindole, but not nor-binaltorphine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37
39. An interaction of opioids and galanin in dorsal horn of the spinal cord in mononeuropathic rats
40. Involvement of neuropeptide Y and Y1 receptor in antinociception in nucleus raphe magnus of rats
41. Use of β-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands